Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and
Plant-based vaccine against SARS-CoV-2 shows promise
Home ยป
Emergent hopes to answer U.S. FDA on Baltimore plant within days
(Reuters) – Contract drugmaker Emergent BioSolutions Inc said on Thursday it hopes to respond to U.S. regulators within days on
Skin and bones repaired by bioprinting during surgery
Fixing traumatic injuries to the skin and bones of the face and skull is difficult because of the many layers